Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$657M |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$587M |
| 4 |
AstraZeneca
AZN
|
+$319M |
| 5 |
Snowflake
SNOW
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$323M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$273M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$121M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$98.6M |
| 5 |
JD.com
JD
|
+$89.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.03% |
| 2 | Financials | 13.72% |
| 3 | Healthcare | 12.6% |
| 4 | Consumer Discretionary | 10.97% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SP
2576
DELISTED
SP Plus Corporation
SP
| $288K | ﹤0.01% |
9,418
+4,531
| +93% | +$141K |
|
2577
Atlanta Braves Holdings Series A
BATRA
$3.43B
| $282K | ﹤0.01% |
10,506
-161
| -2% | -$4.3K |
|
2578
Manitowoc
MTW
$675M
| $282K | ﹤0.01% |
13,139
+6,835
| +108% | +$158K |
|
|
YMAB
2579
DELISTED
Y-mAbs Therapeutics
YMAB
| $282K | ﹤0.01% |
9,914
+5,083
| +105% | +$160K |
|
2580
Aclaris Therapeutics
ACRS
$869M
| $281K | ﹤0.01% |
15,618
+9,446
| +153% | +$151K |
|
|
POSH
2581
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
| $278K | ﹤0.01% |
11,680
+11,249
| +2,610% | +$360K |
|
2582
ALX Oncology
ALXO
$290M
| $276K | ﹤0.01% |
3,742
+1,598
| +75% | +$107K |
|
2583
Compugen
CGEN
$228M
| $276K | ﹤0.01% |
45,963
| – | – |
|
|
VLDR
2584
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
| $276K | ﹤0.01% |
46,586
+19,033
| +69% | +$143K |
|
2585
Applovin
APP
$116B
| $274K | ﹤0.01% |
+3,783
| New | +$257K |
|
|
TTCF
2586
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
| $274K | ﹤0.01% |
14,874
+7,891
| +113% | +$156K |
|
|
PAE
2587
DELISTED
PAE Incorporated Class A Common Stock
PAE
| $273K | ﹤0.01% |
45,720
+12,536
| +38% | +$95.9K |
|
2588
Camden National
CAC
$976M
| $271K | ﹤0.01% |
5,652
+2,739
| +94% | +$126K |
|
2589
QCR Holdings
QCRH
$1.7B
| $271K | ﹤0.01% |
5,258
+3,124
| +146% | +$154K |
|
2590
Pulmonx
LUNG
$87.6M
| $268K | ﹤0.01% |
7,475
+3,702
| +98% | +$146K |
|
2591
Personalis
PSNL
$1.51B
| $268K | ﹤0.01% |
13,861
+6,477
| +88% | +$135K |
|
|
TIXT
2592
DELISTED
TELUS International
TIXT
| $268K | ﹤0.01% |
7,622
+4,147
| +119% | +$134K |
|
2593
Winmark
WINA
$1.32B
| $268K | ﹤0.01% |
1,247
+594
| +91% | +$122K |
|
|
CLVS
2594
DELISTED
Clovis Oncology, Inc.
CLVS
| $268K | ﹤0.01% |
60,188
+20,949
| +53% | +$101K |
|
2595
Freedom Holding
FRHC
$9.49B
| $267K | ﹤0.01% |
4,245
+3,465
| +444% | +$220K |
|
2596
Nurix Therapeutics
NRIX
$2.65B
| $267K | ﹤0.01% |
8,914
+5,241
| +143% | +$162K |
|
|
FBMS
2597
DELISTED
The First Bancshares, Inc.
FBMS
| $265K | ﹤0.01% |
6,820
+4,173
| +158% | +$161K |
|
2598
Spruce Power Holding Corp
SPRU
$39.9M
| $263K | ﹤0.01% |
5,346
+2,604
| +95% | +$139K |
|
2599
Corsair Gaming
CRSR
$1.55B
| $259K | ﹤0.01% |
9,999
+5,417
| +118% | +$155K |
|
|
ACRE
2600
Ares Commercial Real Estate
ACRE
$270M
| $257K | ﹤0.01% |
17,099
+9,309
| +119% | +$141K |
|
Similar funds
Legal & General Group's Q3 2021 Portfolio in Review
As of Q3 2021, Legal & General Group held 3,551 positions worth $308B, up 2.9% from $299B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Legal & General Group deployed $10.7B of net new capital in Q3 2021, opening 77 new positions and adding to 2,293 existing holdings. Its largest new stake was AstraZeneca: 2,738,007 shares worth $329M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was JD.com, an estimated $89.3M trimmed.
- Legal & General Group's largest Q3 2021 buy was AstraZeneca: 2,738,007 shares worth $329M.
- Legal & General Group added most to Microsoft in Q3 2021, an estimated $657M increase.
- Legal & General Group's biggest Q3 2021 reduction was JD.com, cutting an estimated $89.3M.
- Legal & General Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $323M.
- Legal & General Group's ten largest holdings make up 22% of its $308B portfolio in Q3 2021.
- Legal & General Group opened 77 new positions and closed 55 in Q3 2021.
- Legal & General Group's portfolio value rose 2.9% quarter-over-quarter to $308B.
Based on Legal & General Group's 13F filing for Q3 2021, filed 15 Nov 2021.